HomeNews & MediaPress ReleasesPhilogen announces enrolment of 214 patients in the Nidlegy™ Phase III European clinical trial for the treatment of locally advanced melanomaPress ReleasePublishedJuly 25, 2022Philogen announces enrolment of 214 patients in the Nidlegy™ Phase III European clinical trial for the treatment of locally advanced melanomaMore details
